Relationship between DST nonsuppression and shortened REM latency in schizophrenia

Biological Psychiatry

Volumn 40, Issue 7, 1996, Pages 660-663

  Tandon, Rajiv ^a,b   Lewis, Catherine ^a   Taylor, Stephan F ^a   Shipley, James E ^a   DeQuardo, John R ^a   Jibson, Michael ^a   Goldman, Mona ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

cholinergic; cortisol; dexamethasone suppression test; REM latency; schizophrenia; sleep

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; LATENT PERIOD; MALE; PRIORITY JOURNAL; REM SLEEP; SCHIZOPHRENIA;

EID: 0030273352     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(96)00205-3     Document Type: Article

References (29)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, revised. Washington DC: American Psychiatric Association.
2. Andreasen NC (1983): The Scale for the Assessment of Negative Symptoms. Iowa City: The University of Iowa.
3. Asnis GM, Halbreich U, Sachar EJ, Nathan RS, Ostrow LC, Novacenko H, Davis M, Endicott J, Puig-Antich J (1983): Plasma cortisol secretion and REM period latency in adult endogenous depression. Am J Psychiatry 140:750-753.
4. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E (1981): A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15-22.
5. Endicott J, Spitzer RL (1978): A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia (SADS). Arch Gen Psychiatry 35:837-853.
6. Freedman R, Hall M, Adler LE, Leonard S (1995): Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:22-33.
7. Gillin JC, Sutton L, Ruiz D, Kelsoe J, Dupont R, Darko D, Risch SC, Golshan S, Janowsky D (1991): The cholinergic REM induction test with arecoline in depression. Arch Gen Psychiatry 48:264-270.
8. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
9. Holsboer-Trachsler E, Buol C, Wiedemann K, Holsboer F (1987): Dexamethasone suppression test in severe schizophrenic illness: Effects of plasma dexamethasone suppression and caffeine levels. Acta Psychiatr Scand 75:608-613.
10. Janowsky DS, Overstreet DH (1995): The role of acetylcholine mechanisms in mood disorders. In Bloom FE and Kupfer DJ (eds), Psychopharmacology, The Fourth Generation of Progress. New York: Raven Press.
11. Kane JM, Honigfeld G, Singer J, Meltzer HY (1988): Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45: 789-796.
12. Kerkhofs M, Missa J-N, Mendlewicz J (1986): Sleep electroencephalographic measures in primary major depressive disorder: Distinction between DST suppressor and nonsuppressor patients. Biol Psychiatry 21:228-232.
13. Keshavan MS, Tandon R (1993): Sleep abnormalities in schizophrenia: Pathophysiological significance. Psychol Med 23: 831-835.
14. Murphy BE (1967): Some studies of the protein-binding of steroids and their application to the routine micro- and ultra-micro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab 27:973-990.
15. Overall JE, Gorham DR (1962): Brief Psychiatric Rating Scale. Psychological Reports 10:799-812.
16. Poland RE, Tondo L, Rubin RT, Trelease RB, Lesser IM (1989): Differential effects of scopolamine on nocturnal cortisol secretion, sleep architecture, and REM latency in normal volunteers; relation to sleep and cortisol abnormalities in depression. Biol Psychiatry 25:403-412.
17. Rechtschaffen A, Kales A, Berger PA (1968): A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages in Human Subjects. Washington DC: US Public Health Service.
18. Reynolds CF, Kupfer DJ (1987): Sleep research in affective illness: State of the art, circa 1987. Sleep 10:199-215.
19. Riemann D, Hohagen F, Krieger S, Gann H, Muller WE, Olbrich R, Wark H-J, Bonus M, Low H, Berger M (1994): Cholinergic REM induction test: Muscarinic supersensitivity underlies polysomnographic findings in both depression and schizophrenia. Psychiatry Res 28:195-210.
20. Risch SC, Janowsky DS, Gillin JC (1983): Muscarinic supersensitivity of anterior pituitary ACTH and β-endorphin release in major depressive illness. Peptides 4:789-797.
21. Rush AJ, Giles DE, Roffwarg HP, Parker CR (1982): Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar depressive disorders. Biol Psychiatry 17:327-341.
22. Rush AJ, Sclesser MA, Roffwarg HP, Giles DE, Orsulak PJ, Fairchild C (1983): Relationship among the TRH, REM latency, and dexamethasone suppression tests: Preliminary findings. J Clin Psychiatry 44:23-29.
23. Spitzer RL, Endicott J, Robins E (1978): Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 35: 773-782.
24. Tandon R, Greden JF (1989): Cholinergic hyperactivity and negative schizophrenic symptoms. Arch Gen Psychiatry 46:745-753.
25. Tandon R, Goldman R, Goodson J, Greden JF (1990): Mutability and Relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia. Biol Psychiatry 27:1323-1326.
26. Tandon R, Mazzara C, DeQuardo JR, Craig KA, Meador-Woodruff JH, Goldman RS, Greden JF (1991a): Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement and outcome. Biol Psychiatry 29:953-964.
27. Tandon R, Shipley JE, Greden JF, Mann NA, Eisner WH, Goodson J (1991b): Muscarinic cholinergic activity in schizophrenia: Relationship to positive and negative symptoms. Schizophr Res 4:23-30.
28. Tandon R, Shipley JE, Taylor SF, Greden JF, Eiser A, DeQuardo JR, Goodson J (1992): Electroencephalographic sleep abnormalities in schizophrenia. Arch Gen Psychiatry 49:185-194.
29. Zarcone VP, Benson KL, Berger PA (1987): Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry 44:45-48.